Photo from The Netherlands Cancer Institute/X
Jun 7, 2024, 09:11
Results of the NICHE-2 study by Myriam Chalabi – The Netherlands Cancer Institute
The Netherlands Cancer Institute (NKI) shared on X:
“More success for neoadjuvant immunotherapy: results of the NICHE-2 study by Myriam Chalabi show that it is highly effective in a subset of patients with colon cancer.
In 68% of patients there were no live cancer cells.”
Source: The Netherlands Cancer Institute/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 18, 2025, 15:20
Jan 18, 2025, 14:58
Jan 18, 2025, 14:50
Jan 18, 2025, 14:43
Jan 18, 2025, 14:40
Jan 18, 2025, 14:33